Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 53 | 502.5 | 252 | 506.5 | 16 | 150.9** | 126 | 269.2 |
| Esophagus | * | # | 7 | 14.1** | * | # | 6 | 12.9** |
| Stomach | * | # | 6 | 12.0** | * | # | 3 | # |
| Colon excluding Rectum | * | # | 30 | 65.2 | * | # | 8 | 16.3** |
| Rectum and Rectosigmoid Junction | * | # | 12 | 22.1** | * | # | 2 | # |
| Liver | * | # | 3 | # | * | # | 4 | # |
| Pancreas | * | # | 7 | 13.9** | * | # | 5 | 10.2** |
| Lung and Bronchus | 10 | 99.4** | 45 | 89.4 | 6 | 60.1** | 42 | 86.3 |
| Melanoma of the Skin | * | # | 10 | 18.8** | * | # | 3 | # |
| Prostate | 16 | 141.9** | 59 | 113.9 | * | # | 12 | 31.2** |
| Urinary Bladder | * | # | 14 | 29.4** | * | # | 5 | 14.1** |
| Kidney and Renal Pelvis | * | # | 12 | 23.6** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 0 | # |
| Non-Hodgkin Lymphoma | * | # | 9 | 17.3** | * | # | 7 | 15.4** |
| Myeloma | * | # | 2 | # | * | # | 2 | # |
| Leukemia | * | # | 6 | 12.5** | * | # | 6 | 12.3** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 42 | 369.2 | 202 | 351.1 | 22 | 176.0 | 95 | 157.7 |
| Colon excluding Rectum | 10 | 81.7** | 27 | 44.6 | * | # | 10 | 16.4** |
| Rectum and Rectosigmoid Junction | * | # | 3 | # | * | # | 0 | # |
| Liver | * | # | 1 | # | * | # | 0 | # |
| Pancreas | * | # | 5 | 8.4** | * | # | 9 | 14.9** |
| Lung and Bronchus | 8 | 66.9** | 32 | 54.2 | 8 | 65.6** | 22 | 36.7 |
| Melanoma of the Skin | * | # | 4 | # | * | # | 1 | # |
| Breast | 12 | 106.9** | 62 | 108.1 | 5 | 38.4** | 13 | 21.5** |
| Cervix Uteri | * | # | 5 | 9.4** | * | # | 2 | # |
| Corpus Uteri | * | # | 8 | 14.0** | * | # | 0 | # |
| Ovary | * | # | 6 | 10.3** | * | # | 2 | # |
| Urinary Bladder | * | # | 3 | # | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 3 | # | * | # | 0 | # |
| Brain and Other Nervous System | * | # | 2 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 9 | 15.9** | * | # | 7 | 12.3** |
| Myeloma | * | # | 1 | # | * | # | 2 | # |
| Leukemia | * | # | 5 | 9.0** | * | # | 5 | 8.1** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
